Ponesimod--a future oral therapy for psoriasis?

Lancet. 2014 Dec 6;384(9959):2006-8. doi: 10.1016/S0140-6736(14)61039-4. Epub 2014 Aug 10.

Authors

Caitriona Ryan¹, Alan Menter²

Affiliations

¹ Department of Dermatology, Baylor University Medical Center and Texas A&M Health Science Center, Dallas, TX 75246, USA.
² Department of Dermatology, Baylor University Medical Center and Texas A&M Health Science Center, Dallas, TX 75246, USA. Electronic address: amderm@gmail.com.

PMID: 25127207
DOI: 10.1016/S0140-6736(14)61039-4

No abstract available

Publication types

Comment

MeSH terms

Humans
Psoriasis / drug therapy*
Thiazoles / administration & dosage*

Substances

Thiazoles
ponesimod